Cargando…

GD2 oligosaccharide: target for cytotoxic T lymphocytes

Carbohydrate antigens rarely provide target epitopes for cytotoxic T lymphocytes (CTL). Disialoganglioside GD2 is a glycolipid expressed at high levels in human tumors and a small group of murine lymphomas (EL4, RBL5, RMA, RMA-S, A13, and BALBRVE). Immunization of C57B1/6 mice with irradiated EL4 ce...

Descripción completa

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1995
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192096/ https://www.ncbi.nlm.nih.gov/pubmed/7540657

Ejemplares similares

GD2 and GD3 synthase: novel drug targets for cancer therapy
por: Sphyris, Nathalie, et al.
Publicado: (2015)

Targeting cytotoxic T lymphocytes for cancer immunotherapy
por: Maher, J, et al.
Publicado: (2004)

Ganglioside GD3 synthase (GD3S), a novel cancer drug target
por: Liu, Jinyi, et al.
Publicado: (2018)

Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy
por: Fleurence, Julien, et al.
Publicado: (2017)

Internal dose assessment of (148)Gd using isotope ratios of gamma-emitting (146)Gd or (153)Gd in accidently released spallation target particles
por: Rääf, C., et al.
Publicado: (2020)

Digital TDPAC with rare earth isotope $^{169}$Yb, $^{147}$Gd, and $^{149}$Gd in Yb and Gd Doped CeO$_{2}$ and $^{147}$Gd in GdBa$_{2}$ Cu$_{3}$ O$_{7−\delta}$
por: Roeder, Jens, et al.
Publicado: (2011)

Targeting NFκB signaling in GD2(+) BCSCs
por: Nguyen, Khoa, et al.
Publicado: (2017)

Cytotoxic T lymphocytes require transcription for infiltration but not target cell lysis
por: Richard, Arianne C, et al.
Publicado: (2023)

The Kinematics of Cytotoxic Lymphocytes Influence Their Ability to Kill Target Cells
por: Bhat, Purnima, et al.
Publicado: (2014)

Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy
por: Lazear, Eric, et al.
Publicado: (2017)

Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells
por: Yankelevich, Maxim, et al.
Publicado: (2023)

Complex of GM1- and GD1a-Like Lipo-Oligosaccharide Mimics GM1b, Inducing Anti-GM1b Antibodies
por: Koga, Michiaki, et al.
Publicado: (2015)

Expression of GD2 and GD3 gangliosides in human embryonic neural stem cells
por: Yanagisawa, Makoto, et al.
Publicado: (2011)

Self-patterning Gd nano-fibers in Mg-Gd alloys
por: Li, Yangxin, et al.
Publicado: (2016)

Resistance of cloned cytotoxic T lymphocytes to cell-mediated cytotoxicity
Publicado: (1987)

Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2(+) breast cancer stem-like cells
por: Ly, Stanley, et al.
Publicado: (2021)

Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment
por: Kim, Kyun-Do, et al.
Publicado: (2017)

FLT3-regulated antigens as targets for leukemia-reactive cytotoxic T lymphocytes
por: Brackertz, B, et al.
Publicado: (2011)

High Glucose Enhances Cytotoxic T Lymphocyte-Mediated Cytotoxicity
por: Zhu, Jie, et al.
Publicado: (2021)

Correction: The Kinematics of Cytotoxic Lymphocytes Influence Their Ability to Kill Target Cells
Publicado: (2014)

Supramolecular attack particle: the way cytotoxic T lymphocytes kill target cells
por: Liu, Jiaqi, et al.
Publicado: (2020)

Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
por: Fleurence, Julien, et al.
Publicado: (2016)

Neuroblastoma GD2 Expression and Computational Analysis of Aptamer-Based Bioaffinity Targeting
por: Sabbih, Godfred O., et al.
Publicado: (2021)

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors
por: Kalinovsky, Daniel V, et al.
Publicado: (2022)

Extracellular Cystatin F Is Internalised by Cytotoxic T Lymphocytes and Decreases Their Cytotoxicity
por: Prunk, Mateja, et al.
Publicado: (2020)

GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
por: Park, Jeong A., et al.
Publicado: (2020)

Giant exchange coupling and field-induced slow relaxation of magnetization in Gd(2)@C(79)N with a single-electron Gd–Gd bond
por: Velkos, G., et al.
Publicado: (2018)

Cytotoxic T Lymphocytes and Vaccine Development
por: Xiao, Zhengguo, et al.
Publicado: (2010)

The effects of three different contrast agents (Gd-BOPTA, Gd-DTPA, and Gd-DOTA) on brachial plexus magnetic resonance imaging
por: Zhang, Xiaojing, et al.
Publicado: (2021)

GD2 expression in breast cancer
por: Orsi, Giulia, et al.
Publicado: (2017)

Chitosan Oligosaccharides Attenuate Amyloid Formation of hIAPP and Protect Pancreatic β-Cells from Cytotoxicity
por: Meng, Qin-Yu, et al.
Publicado: (2020)

Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors
por: Golinelli, Giulia, et al.
Publicado: (2018)

Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target
Publicado: (1994)

Localization of aggregated cell surface antigens of target cells bound to cytotoxic T lymphocytes
Publicado: (1975)

Characterization and cytotoxicity of low-molecular-weight chitosan and chito-oligosaccharides derived from tilapia fish scales
por: Chaudhry, Gul-e-Saba, et al.
Publicado: (2021)

Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins
Publicado: (1986)

Targeting Oligosaccharides and Glycoconjugates Using Superselective Binding Scaffolds
por: Tommasone, Stefano, et al.
Publicado: (2020)

Red Blood Cells Oligosaccharides as Targets for Plasmodium Invasion
por: Burzyńska, Patrycja, et al.
Publicado: (2022)

Antigen presentation to cytotoxic T lymphocytes in vivo
Publicado: (1995)

CYTOTOXIC POTENTIAL OF STIMULATED HUMAN LYMPHOCYTES
por: Holm, Göran, et al.
Publicado: (1967)

Cannot write session to /tmp/vufind_sessions/sess_70vvqvj3fpvs4qugk40ki5nqua